Merck KGaA (MRK)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

€

Buy

€

arrow-up€ (+%)

Prices updated at 29 Jan 2025, 23:05

Prices minimum 15 mins delay

Prices in EUR

Merck KGaA is a pharmaceutical and chemical company. It offers prescription medicines, diagnostics, and products used in allergen immunotherapy, specialty chemicals, and probiotic nutritional supplements.

FTSE EuroFirst 300

0.54%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

Key dates

	Forecast date
Half yearly results	Aug 2025
Annual general meeting	Apr 2025
Annual report	Mar 2025
Final results	Mar 2025

	Previous date
Half yearly results	Aug 2024
Annual general meeting	Apr 2024
Annual report	Mar 2024
Final results	Mar 2024

Company reports

31 Dec 2023

Annual Report

31 Dec 2023

Quarterly Report

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.